my account
Login
  Loading... Please wait...

Product Details

Ibandronate | Farnesyl pyrophosphatase synthase inhibitor / osteoporosis drug

Ibandronate (138926-19-9) is a clinically useful drug for the prevention and treatment of osteoporosis and skeletal fractures in patients with cancer.  It is a potent inhibitor of farnesyl pyrophosphate synthase (IC50 = 20 nM) and strongly binds to hydroxyapatite.1

References/Citations

1) Russell (2006), Ibandronate: Pharmacology and preclinical studies; Bone 38 S7

swipe
Focus Biomolecules supplier, chemical structure Ibandronate | Farnesyl pyrophosphatase synthase inhibitor | CAS 138926-19-9

Catalog#  10-4630-0050

$30.00
Quantity
Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee.
 
Request Bulk Quote
CAS:
138926-19-9
Catalog Number:
10-4630
Activity:
Farnesyl pyrophosphatase synthase inhibitor / osteoporosis drug
Chemical Name:
(1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonic acid sodium monohydrate
Molecular Weight:
359.23
Molecular Formula:
C9H22NO7P2 • Na • H2O
Solubility:
Soluble in DMSO (up to at least 25 mg/ml)
Physical Properties:
White solid
Purity:
98%
NMR (Conforms)
Storage Temperature:
-20°C (des.)
Stability:
Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Shipping Code:
RT
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications.

Focus BiomoleculesPlymouth Meeting, PA USA1-855-FOCUS21

Connect with Focus

Click the button below to add the Ibandronate | Farnesyl pyrophosphatase synthase inhibitor / osteoporosis drug to your wish list.